We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Device Predicts when Critically Ill Patients Can Be Safely Removed from Ventilator

By HospiMedica International staff writers
Posted on 01 Jul 2022

Over the last two years of the pandemic, more people than ever have experienced extreme difficulty breathing, requiring mechanical ventilation (intubation) in critical care units across the world. More...

A mechanical ventilator is a machine that helps patients breathe when they cannot breathe on their own due to critical illness, such as COVID-19, or surgery. The machine is connected to a breathing tube that is inserted into the patient’s trachea. The process of intubating (inserting the tube) and extubating (removing the tube) is very complex, and anyone requiring ventilation will require months of recovery and rehabilitation to learn how to swallow, eat, talk and breathe again. Currently, there is no patient monitoring equipment to help physicians decide the best time to remove a patient from a ventilator to improve their outcomes, but that may be just about to change.

The Ottawa Hospital (Ontario, Canada) has become the first hospital in the world to evaluate an innovative medical device that uses artificial intelligence (AI) to predict when critically ill patients are ready to breathe on their own. Over the last 13 years, the team that developed the device has made major progress in using complex mathematics, AI and routinely collected vital sign data to predict when patients are ready to be extubated. The device, called the Extubation Advisor, constantly monitors and analyzes a patient’s vital signs, including blood pressure, oxygen levels, breathing rhythms and heart rate during their ventilation. Then, it uses AI to provide doctors with a specific read of when the patient can be safely removed from the ventilator.

This is the first time that real-time predictive analytics based on this type of high-frequency data is being used and evaluated at the bedside. The system was used for three months at the bedside of ventilated patients in The Ottawa Hospital’s Intensive Care Unit (ICU), with permission from their families. After the successful initial evaluation, the metrics are looking promising, and the feedback received from physicians was very positive. The team hopes that the device will help improve patient safety and outcomes in the near future. The team’s next steps include a randomized controlled trial. With each milestone, they are one step closer to transforming care for some of the sickest patients treated at hospitals.

“Currently, one in every seven ICU patients experiences extubation failure. Prolonged ventilation harms patients, and early extubation requiring reintubation can be a devastating blow to their recovery,” said Dr. Andrew Seely, a critical care physician, thoracic surgeon and scientist at The Ottawa Hospital, who developed the device. “We’ve developed the first medical device to offer extubation decision support, which we believe will help standardize and improve care.”

Related Links:
The Ottawa Hospital 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.